Dr. Bonn-Miller to lead clinical science
supporting product development, CBD regulation, alternative
botanical wellness
DENVER, March 8,
2023 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF)
Charlotte's Web Holdings, Inc.
("Charlotte's Web" or the
"Company"), the market leader in cannabidiol ("CBD") hemp extract
wellness products has appointed Dr. Marcel
Bonn-Miller, Ph.D. as its Chief Scientific Officer.
Dr. Bonn-Miller brings more than two decades of
cannabis/cannabinoid research experience to Charlotte's Web. Prior to joining Charlotte's Web, he served four years at
Canopy Growth Corporation, most recently as Vice-President of Human
and Animal Research. In addition to his work at Canopy Growth
Corporation, Dr. Bonn-Miller has held positions as Director of
Cannabinoid Research at Zynerba Pharmaceuticals, Adjunct Assistant
Professor at the University of
Pennsylvania Perelman School of Medicine, and Health Science
Specialist at the Department of Veterans Affairs in Palo Alto, California.
In his new role, Dr. Bonn-Miller will lead the Company's R&D
portfolio, including new product development, pre-clinical and
clinical research, scientific regulatory support, and alternative
botanical wellness. He will build upon the Company's existing
safety and toxicology data and interface with the FDA's science
teams to support regulatory pathways for hemp CBD extracts.
"The known and potential therapeutic effects of the hemp plant
and its compounds are extraordinary," said Dr. Bonn-Miller. "A
natural therapeutic from such a complex plant requires exceptional
consistency in genetics and cultivation. This is where Charlotte's Web has uniquely excelled and
provides an unprecedented opportunity to apply the significant
knowledge accumulated over recent years in cannabinoid
science."
Dr. Bonn-Miller has published over 150 research papers on
cannabinoid science and co-authored three patents related to the
use of cannabidiol (CBD) in the treatment of psychological
illnesses. Additionally, he has formally reviewed a significant
number of medical articles and books on cannabinoids, addiction,
and behavioral psychology and serves on the editorial boards of a
number of scientific journals.
"We are honored to have Dr. Bonn-Miller join Charlotte's Web to lead our clinical science
initiatives," said Jacques
Tortoroli, Chief Executive Officer of Charlotte's Web. "His unparalleled clinical
research record in cannabinoids is highly applicable for supporting
our regulatory and scientific ambitions."
Dr. Bonn-Miller has received numerous research grants and awards
of recognition for his research, including Researcher of the Year
by Americans for Safe Access. He holds a Doctor of Philosophy
(Ph.D.) in Clinical Psychology from the University of Vermont and was a postdoctoral fellow
in the Center for Health Care Evaluation at the Veterans Affairs
Palo Alto Health Care System & Department of Psychiatry and
Behavioral Sciences at Stanford
University School of Medicine. He is a member of the
International Cannabinoid Research Society (ICRS) , American
Psychological Association (APA), and College of Problems on Drug
Dependence (CPDD).
Subscribe to Charlotte's Web
investor news.
About Charlotte's Web Holdings, Inc.
Charlotte's Web Holdings, Inc.,
a Certified B Corporation headquartered in Denver, is the market leader in innovative
hemp extract wellness products under a family of brands that
includes Charlotte's Web™, CBD
Medic™, and CBD Clinic™. Charlotte's Web whole-plant CBD extracts come
in full-spectrum and broad-spectrum (THC-free) options, including
the world's only broad-spectrum CBD certified NSF for Sport®, which
is the official CBD of Major League Baseball©. Founded by the seven
Stanley Brothers, Charlotte's Web ignited the CBD industry when
the brothers came to global prominence with the coverage of a young
girl's astounding reaction to their hemp extract. Their advocacy
changed laws, public perception, and research around the vast
health potential of plant-based solutions. The Stanleys built their
business with the mission to bring safe, botanical options to
health seekers worldwide. Charlotte's Web branded premium quality
products start with proprietary hemp genetics that are American
farm-grown using organic and regenerative cultivation practices.
The Company's hemp extracts have naturally occurring botanical
compounds including cannabidiol ("CBD"), CBC, CBG, terpenes,
flavonoids, and other beneficial compounds. The Company's CW Labs
R&D division advances hemp science at a center of excellence in
Louisville, Colorado. Charlotte's Web product categories include CBD
oil tinctures (liquid products) CBD gummies (sleep, stress,
exercise recovery), CBD capsules, CBD topical creams and lotions,
as well as CBD pet products for dogs. Through its
substantially vertically integrated business model, Charlotte's Web maintains stringent control
over product quality and consistency with 20+ product lot testing
for quality assurance. Charlotte's
Web products are distributed to retailers and health care
practitioners throughout the U.S.A, and online through the Company's
website at www.charlottesweb.com.
© Major League Baseball trademarks and copyrights are used with
permission of Major League Baseball. Visit MLB.com.
Forward-Looking
Information
Certain information in this news release constitutes
forward-looking statements and forward-looking information within
the meaning of applicable securities laws (collectively,
"forward-looking information"). In some cases, but not
necessarily in all cases, forward looking information can be
identified by the use of forward-looking terminology such as
"plans", "targets", "expects" or "does not expect", "is expected",
"an opportunity exists", "is positioned", "estimates", "intends",
"assumes", "anticipates" or "does not anticipate" or "believes", or
variations of such words and phrases or state that certain
actions, events or results "may", "could", "would", "might", "will"
or "will be taken", "occur" or "be achieved". In addition, any
statements that refer to expectations, projections or other
characterizations of future events or circumstances contain
forward-looking information.
Statements containing forward-looking information are not
historical facts, but instead represent management's current
expectations, estimates and projections regarding the future of
our business, future plans, strategies, projections, anticipated
events and trends, the economy and other future conditions.
Forward-looking information is necessarily based on a number of
opinions, assumptions and estimates that, while considered
reasonable by the Company as of the date of this news release, are
subject to known and unknown risks, uncertainties, assumptions and
other factors that may cause the actual results, level of activity,
performance or achievements to be materially different from those
expressed or implied by such statements containing forward-looking
information. Although these statements containing forward-looking
information are based on assumptions the Company considers to be
reasonable based on the information available on the date such
statements are made, such statements are not guarantees of future
performance and readers are cautioned against placing undue
reliance on forward-looking information.
The material factors and assumptions used to develop the
forward-looking information herein include, but are not limited to,
international and political considerations; regulatory changes;
and the factors discussed throughout the "Risk Factors" section of
the Company's most recently filed annual information form available
on www.SEDAR.com and in the Company's most
recently filed Annual Report on Form 10-K and quarterly report on
Form 10-Q as amended, and other filings with the Securities and
Exchange Commission available on www.SEC.gov. Except
as required by applicable securities laws, the Company undertakes
no obligation to publicly update any forward-looking information,
whether written or oral, that may be made from time to time,
whether as a result of new information, future developments or
otherwise.
Charlotte's Web Holdings,
Inc.
THE WORLD'S MOST TRUSTED HEMP EXTRACT™
View original content to download
multimedia:https://www.prnewswire.com/news-releases/charlottes-web-appoints-marcel-bonn-miller-phd-as-chief-scientific-officer-301765700.html
SOURCE Charlotte's Web
Holdings, Inc.